Cargando…

HDL, heart disease, and the lung

Detalles Bibliográficos
Autores principales:	Frey, Kathrin, von Eckardstein, Arnold
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Biochemistry and Molecular Biology 2022
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9131245/ https://www.ncbi.nlm.nih.gov/pubmed/35487261 http://dx.doi.org/10.1016/j.jlr.2022.100217

Ejemplares similares

Apolipoprotein M and Sphingosine-1-Phosphate: A Potentially Antidiabetic Tandem Carried by HDL
por: Yalcinkaya, Mustafa, et al.
Publicado: (2020)

HDL – Quo vadis
por: von Eckardstein, Arnold, et al.
Publicado: (2023)

The Endothelium Is Both a Target and a Barrier of HDL’s Protective Functions
por: Robert, Jérôme, et al.
Publicado: (2021)

Frail HDLs and Stiff Arteries in Type 2 Diabetes in Juveniles
por: von Eckardstein, Arnold, et al.
Publicado: (2013)

HDL Cholesterol Story Is Dead: Long Live HDL!
por: Simha, Vinaya, et al.
Publicado: (2016)

Hepatocyte ABCA1 deficiency is associated with reduced HDL sphingolipids
por: Othman, Alaa, et al.
Publicado: (2023)

HDL cholesterol: reappraisal of its clinical relevance
por: März, Winfried, et al.
Publicado: (2017)

Decoding Functional High-Density Lipoprotein Particle Surfaceome Interactions
por: Frey, Kathrin, et al.
Publicado: (2022)

The bidirectional link between HDL and COVID-19 infections
por: Feingold, Kenneth R.
Publicado: (2021)

The usefulness of information on HDL-cholesterol: potential pitfalls of conventional assumptions
por: Furberg, Curt D
Publicado: (2001)

HDL dysfunction, function, and heart failure
por: Mishra, Mudit, et al.
Publicado: (2019)

Alterations of HDL’s to piHDL’s Proteome in Patients with Chronic Inflammatory Diseases, and HDL-Targeted Therapies
por: Vyletelová, Veronika, et al.
Publicado: (2022)

Importance of Apolipoprotein A-I and A-II Composition in HDL and Its Potential for Studying COVID-19 and SARS-CoV-2
por: Cho, Kyung-Hyun
Publicado: (2021)

Is the way to man's heart (and lung) through the abdomen?
por: Owens, Robert L, et al.
Publicado: (2009)

HDL Composition, Heart Failure, and Its Comorbidities
por: Diab, Ahmed, et al.
Publicado: (2022)

Bile Acid Metabolites in Serum: Intraindividual Variation and Associations with Coronary Heart Disease, Metabolic Syndrome and Diabetes Mellitus
por: Steiner, Carine, et al.
Publicado: (2011)

Predictive value of LDL/HDL ratio in coronary atherosclerotic heart disease
por: Sun, Ting, et al.
Publicado: (2022)

Coronary Heart Disease Risks Associated with High Levels of HDL Cholesterol
por: Wilkins, John T., et al.
Publicado: (2014)

Commentary: Power-washing the brain with the heart-lung machine?
por: Angelini, Gianni D., et al.
Publicado: (2020)

The Role of HDL and HDL Mimetic Peptides as Potential Therapeutics for Alzheimer’s Disease
por: Chernick, Dustin, et al.
Publicado: (2020)

HDL subclasses and mortality in acute heart failure patients
por: Degoricija, Vesna, et al.
Publicado: (2019)

The association of HDL-apoCIII with coronary heart disease and the effect of statin treatment on it
por: Xiong, Xiaowei, et al.
Publicado: (2015)

Wet lungs, broken hearts and difficult therapies after subarachnoid hemorrhage
por: Stocchetti, Nino
Publicado: (2010)

β(2 )adrenergic agonists in acute lung injury? The heart of the matter
por: Lee, Jae W
Publicado: (2009)

Myeloperoxidase mediated HDL oxidation and HDL proteome changes do not contribute to dysfunctional HDL in Chinese subjects with coronary artery disease
por: Wang, Guisong, et al.
Publicado: (2018)

HDL and chronic kidney disease
por: Pavanello, Chiara, et al.
Publicado: (2023)

Association of total cholesterol and HDL-C levels and outcome in coronary heart disease patients with heart failure
por: Zhao, Qin, et al.
Publicado: (2017)

Prognostic significance of TG/HDL-C and non-HDL-C/HDL-C ratios in patients with non-small cell lung cancer: a retrospective study
por: Kong, Lingxin, et al.
Publicado: (2022)

COVID-19 in Fabry disease: a reference center prospective study
por: Bothou, Christina, et al.
Publicado: (2022)

Impaired HDL2-mediated cholesterol efflux is associated with metabolic syndrome in families with early onset coronary heart disease and low HDL-cholesterol level
por: Paavola, Timo, et al.
Publicado: (2017)

Cellular cardiomyoplasty with autologous skeletal myoblasts for ischemic heart disease and heart failure
por: Taylor, Doris A
Publicado: (2001)

Pulmonary hypertension in left heart disease
por: Mehra, Pratishtha, et al.
Publicado: (2017)

Heart disease in women: the role of imaging
por: van der Bijl, P., et al.
Publicado: (2019)

Heart disease and stroke: Down, but not out
por: Kottke, Thomas E., et al.
Publicado: (2021)

The Current Status of Research on High-Density Lipoproteins (HDL): A Paradigm Shift from HDL Quantity to HDL Quality and HDL Functionality
por: Cho, Kyung-Hyun
Publicado: (2022)

Subfractions of high-density lipoprotein (HDL) and dysfunctional HDL in chronic kidney disease patients
por: Rysz-Górzyńska, Magdalena, et al.
Publicado: (2016)

Assessing HDL Metabolism in Subjects with Elevated Levels of HDL Cholesterol and Coronary Artery Disease
por: Hancock-Cerutti, William, et al.
Publicado: (2021)

The possible role of TyG index and TRG/HDL, CRP/HDL, NEUTROPHILS/HDL lymphocytes/HDL ratios in disease severity and outcomes in COVID-19 hospitalized patients with arterial hypertension
por: Liontos, A., et al.
Publicado: (2022)

Tachometer for Reverse Cholesterol Transport?
por: Eckardstein, Arnold
Publicado: (2012)

Statin-Induced Increase in HDL-C and Renal Function in Coronary Heart Disease Patients(§)
por: Athyros, Vasilios G, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_8gqdqqajqcl9hlhktpq42ost06